{"database": "openregs", "table": "dockets", "rows": [["FDA-2005-P-0124", "FDA", "Re-Listing Petition to determine that two strenghths, 50 mg and 250 mg lamotrigene oral tablets, were not withdrawn due to safety nor efficacy concerns", "Nonrulemaking", "2021-09-01T01:01:15Z", "0b0000648043fc25"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-P-0124"], "units": {}, "query_ms": 85.05633205641061, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}